Skip Navigation



JAC Advance Access published online on October 16, 2003

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg456
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/5/776    most recent
dkg456v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scudeller, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scudeller, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Original article

HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations

Luigia Scudeller 1 , Carlo Torti 2 *, Eugenia Quiros-Roldan 2 , Andrea Patroni 3 , Sergio Lo Caputo 4 , Francesca Moretti 2 , Francesco Mazzotta 4 , Elisa Donati 5 , Angela Vivarelli 6 , Giampiero Carosi 2 , and the GenPheRex Group of the MASTER cohort

1 Institute of Infectious Diseases, University of Udine, Udine;
2 Institute of Infectious and Tropical Diseases, University of Brescia, P. le Spedali Civili, 1, 25123 Brescia;
3 Institute of Infectious and Tropical Diseases, University of Brescia, P. le Spedali Civili, 1, 25123 Brescia; Biostatistics Unit, IRCCS Policlinico S. Matteo, Pavia;
4 S.M. Annunziata Hospital, ASL Firenze, Florence;
5 Department of Infectious Diseases, ASL Grosseto, Grosseto;
6 Department of Infectious Diseases, ASL Pistoia, Pistoia, Italy

* Corresponding author. E-mail: carlotorti{at}hotmail.com.

Received 25 March 2003 ; revised 31 July 2003 ; accepted 22 August 2003

Abstract

Objectives: The objective was to study genotypic correlates of discordant interpretations of amprenavir (APV) resistance between a rules-based algorithm and either recombinant phenotype or virtual phenotype.

Methods: HIV resistance mutations found in patients from the GenPheRex study were interpreted with VGI-TRUGENE (version 5.0; VGI) and compared with either recombinant-phenotype (Antivirogram, r-PHT) or virtual-phenotype (Virtual-Phenotype, v-PHT) interpreted through Virco biological cut-offs.

Results: Among 180 samples available, 56 (31.1%) were discordant with the observed genotype interpretation results, as a result of being judged as sensitive by r-PHT or v-PHT but resistant by VGI (S/R). Only the I84V mutation was almost invariably found in concordant resistant isolates compared with S/R isolates (60% versus 0%, respectively; P < 0.0001). Notwithstanding this, the number of multi-protease inhibitor-associated mutations (PAMs) was significantly higher in the concordant resistant isolates; the prevalence of >3 PAMs was 56.52% versus 33.93% in R/R and S/R isolates, respectively (P = 0.01). Correspondence analysis confirmed the relevance of PAMs, although additional mutations appeared to be correlated with APV resistance.

Conclusions: The rate of discordance between rules-based and either r-PHT or v-PHT interpretations for APV was high. Mutation I84V and accumulation of >3 PAMs were found to be associated with resistance as interpreted with all systems tested. However, our results indicate that a number of mutations may have an impact on APV resistance, but that they are missed by current interpretation algorithms and this merits further investigations.

Keywords: genotyping, phenotyping, discordances, mutations
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.